Publications Board Minutes Agendas Newsletters Guidance Documents Reports News Releases Board Actions Guidance Documents General Information Compounding Terminal Distributor Requirements for Prescribers Possessing Compounded Drugs or Engaging in Drug CompoundingCompounding in OhioDrugs Compounded in a Pharmacy Must Adhere to the U.S. Pharmacopeia Conv...Ohio Licensed Outsourcing FacilitiesCompounding for Drug ShortagesClarification on Dilution or Reconstitution of Allergen ExtractsRegistering as a 503B Outsourcing FacilityHazardous Drug Compounding by Prescribers Consult Agreements Pharmacist Consult Agreement with Physicians Controlled Substances Prescribing Qsymia® and Belviq® for Chronic Weight Management Prescibing Opioids to MinorsFor Prescribers - New Limits on Prescription Opioids for Acute PainFor Pharmacists - New Limits on Prescription Opioids for Acute PainStatement on EpidiolexDiagnosis Code Prescription Requirement - ResolutionNew Requirements for Opioid Prescriptions - Effective 4.6.2017Clarification on Transfer of Unfilled Controlled Substance PrescriptionsShort-term Weight Loss Anorexiants FAQControlled Substance Inventory RequirementsChanges in Ohio Law Impacting Buprenorphine Used for the Purpose of Treating Drug Dependence or AddictionTramadol is a Schedule IV Controlled Substance - Effective August 18. 2014Rescheduling of Hydrocodone Combination Products Effective October 6, 2014 Dangerous Drugs Point of Dispensing Locations in a Declared Public Health EmergencyAddressing Possible Shortages of Oseltamivir Products Used to Treat InfluenzaIssuing a Valid Prescription - What Every Prescriber Needs to KnowDispensing of Emergency Refill of Medication without a PrescriptionAdministration of Injections by PharmacistsDispensing Multiple Simultaneous Refills of PrescriptionsExpedited Partner Therapy (EPT)Storage of Records Outside of the Pharmacy DepartmentProcurement of Epinephrine Autoinjectors by Schools and CampsDelivery of Non-Self Injectable Drugs Drug Repository Programs Drugs Collected by a Drug Repository Program Drug Disposal Drug Disposal Resources Correctional Facility Destruction of Patient-Specific Controlled SubstancesControlled Substance Inventory DisposalDrug Enforcement Administration Releases New Rules on Pharmaceutical Drug Collection Electronic Prescribing Approval of Electronic Prescription Transmission Systems & Computerized Prescriber Order Entry SystemsNew Guidance - Printing of Electronic Prescriptions Emergency Medical Services Emergency Medical Services - Frequently Asked QuestionsOccasional Wholesale Sales by EMS Agencies in the Event of a Drug Shortage Immunizations Guidance Document - Immunizations by Pharmacists and Pharmacy InternsApproved Immunization CoursesPharmacist Use of the Ohio Impact Statewide Immunization Information System Key Boxes Use of Key Boxes by First Responders to Obtain Access to a Pharmacy Medical Marijuana Control Program Licensee Participation in the Ohio Medical Marijuana Control ProgramCBD Oil FAQClarification on CBD Oil Naloxone Naloxone Resources Ohio Automated Rx Reporting System OARRS Rules & Corresponding Responsibility Reporting Naltrexone Products to OARRS - Effective 3.19.2019DEA Plus Suffix Upload InstructionsReporting Gabapentin Products to OARRS – Effective 12-1-2016H.B. 341 - Mandatory OARRS Registration and RequestsOARRS Integration Fact SheetCoroner Use of the Ohio Automated Rx Reporting System Pain Management Clinics Responsible Person Requirements for Pain Management Clinics Positive Identification Positive Identification for EMSPositive Identification And Hospital Electronic Drug Record Keeping Systems Protocols Influenza Outbreak Management in Long-Term Care Facilities by Emergency ProtocolJoint Regulatory Statement - Use of Protocols to Initiate or Adjust Medications Suspicious Order Monitoring Suspicious Order Monitoring and Due Diligence Theft or Loss Reporting Reporting Theft or Loss of Dangerous Drugs and Drug DocumentsSubmitting Theft or Loss Reports